Amgen Inc. buy Argus
Start price
18.09.23
/
50%
€246.20
Target price
18.09.24
€262.05
Performance (%)
22.28%
End price
19.09.24
€301.05
Summary
This prediction ended on 19.09.24 with a price of €301.05. The prediction had a final performance of 22.28%. Argus has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €8.16 are taken into consideration when calculating the performance. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -0.795% | -0.795% | 19.219% |
| iShares Core DAX® | 2,55 % | -0,11 % | 15,00 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % | 30,95 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % | 49,70 % |
| iShares S&P 500 | 1,93 % | -0,52 % | 24,88 % |
Comments by Argus for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target raised by analysts at Argus from $260.00 to $280.00. They now have a "buy" rating on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Argus gewählte maximale Laufzeit wurde überschritten